1. Blood. 2016 Jan 21;127(3):333-42. doi: 10.1182/blood-2015-07-661983. Epub 2015
 Oct 8.

Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative 
essential thrombocythemia patients.

Cabagnols X(1), Favale F(1), Pasquier F(1), Messaoudi K(1), Defour JP(2), 
Ianotto JC(3), Marzac C(4), Le Couédic JP(1), Droin N(1), Chachoua I(2), Favier 
R(1), Diop MK(1), Ugo V(5), Casadevall N(6), Debili N(1), Raslova H(1), 
Bellanné-Chantelot C(7), Constantinescu SN(2), Bluteau O(1), Plo I(1), 
Vainchenker W(8).

Author information:
(1)INSERM, Unité Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, 
France; Université Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France; 
UMR1170, Gustave Roussy, Villejuif, France;
(2)de Duve Institute, Université Catholique de Louvain, Brussels, Belgium; 
Ludwig Institute for Cancer Research, Signal Transduction & Molecular Hematology 
Unit, Brussels, Belgium;
(3)Service d'Hématologie, Centre Hospitalier Universitaire (CHU) Brest, Brest, 
France;
(4)Laboratoire d'Hématologie, Hôpital Saint Antoine, Assistance 
Publique-Hôpitaux de Paris, Paris, France;
(5)Laboratoire d'Hématologie, CHU Brest, Brest, France;
(6)INSERM, Unité Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, 
France; Université Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France; 
UMR1170, Gustave Roussy, Villejuif, France; Laboratoire d'Hématologie, Hôpital 
Saint Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France;
(7)INSERM, Unité Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, 
France; Université Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France; 
UMR1170, Gustave Roussy, Villejuif, France; Département de Génétique, Hôpital 
Pitié-Salpêtrière, Université Pierre et Marie Curie, Assistance 
Publique-Hôpitaux de Paris, Paris, France; and.
(8)INSERM, Unité Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, 
France; Université Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France; 
UMR1170, Gustave Roussy, Villejuif, France; Consultation 
d'Hématologie-Immunologie, Hôpital Saint Louis, Assistance Publique-Hôpitaux de 
Paris, Paris, France.

Mutations in signaling molecules of the cytokine receptor axis play a central 
role in myeloproliferative neoplasm (MPN) pathogenesis. Polycythemia vera is 
mainly related to JAK2 mutations, whereas a wider mutational spectrum is 
detected in essential thrombocythemia (ET) with mutations in JAK2, the 
thrombopoietin (TPO) receptor (MPL), and the calreticulin (CALR) genes. Here, we 
studied the mutational profile of 17 ET patients negative for JAK2V617F, 
MPLW515K/L, and CALR mutations, using whole-exome sequencing and next-generation 
sequencing (NGS) targeted on JAK2 and MPL. We found several signaling mutations 
including JAK2V617F at very low allele frequency, 1 homozygous SH2B3 mutation, 1 
MPLS505N, 1 MPLW515R, and 2 MPLS204P mutations. In the remaining patients, 4 
presented a clonal and 7 a polyclonal hematopoiesis, suggesting that certain 
triple-negative ETs are not MPNs. NGS on 26 additional triple-negative ETs 
detected only 1 MPLY591N mutation. Functional studies on MPLS204P and MPLY591N 
revealed that they are weak gain-of-function mutants increasing MPL signaling 
and conferring either TPO hypersensitivity or independence to expressing cells, 
but with a low efficiency. Further studies should be performed to precisely 
determine the frequency of MPLS204 and MPLY591 mutants in a bigger cohort of 
MPN.

© 2016 by The American Society of Hematology.

DOI: 10.1182/blood-2015-07-661983
PMID: 26450985 [Indexed for MEDLINE]